Clinical trials
Cardiomyopathies trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 6 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 6 |
| Ancora Heart, Inc. | 2 |
| Eidos Therapeutics, a BridgeBio company | 2 |
| Universitaire Ziekenhuizen KU Leuven | 2 |
| Bayer | 1 |
| Biosense Webster, Inc. | 1 |
| Celladon Corporation | 1 |
| Intellia Therapeutics | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| Medtronic Cardiac Rhythm and Heart Failure | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathies | 22 |
| Heart Failure | 11 |
| Amyloidosis | 9 |
| Alzheimer Disease | 4 |
| Amyloid Neuropathies, Familial | 4 |
| Amyloidosis, Familial | 3 |
| Heart Diseases | 3 |
| Amyloid Neuropathies | 2 |
| Arrhythmias, Cardiac | 2 |
| Atrial Fibrillation | 2 |
Trials
Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.